632 related articles for article (PubMed ID: 10349439)
1. [The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection].
Alvarez Vera M; Valdés Palacios D; Vázquez Ramudo S; Delgado Hernández I; García Infante S; Morier Díaz L; Guzmán Tirado MG
Rev Cubana Med Trop; 1998; 50(3):177-81. PubMed ID: 10349439
[TBL] [Abstract][Full Text] [Related]
2. Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.
Mantel N; Aguirre M; Gulia S; Girerd-Chambaz Y; Colombani S; Moste C; Barban V
J Virol Methods; 2008 Jul; 151(1):40-6. PubMed ID: 18501437
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus.
Germi R; Crance JM; Garin D; Guimet J; Lortat-Jacob H; Ruigrok RW; Zarski JP; Drouet E
Virology; 2002 Jan; 292(1):162-8. PubMed ID: 11878919
[TBL] [Abstract][Full Text] [Related]
4. [Serological diagnosis of dengue and yellow fever infections in suspected cases from Pará State, Brazil, 1999].
de Araújo TP; Rodrigues SG; Costa MI; Vasconcelos PF; da Rosa AP
Rev Soc Bras Med Trop; 2002; 35(6):579-84. PubMed ID: 12612738
[TBL] [Abstract][Full Text] [Related]
5. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?
Gubler DJ
Comp Immunol Microbiol Infect Dis; 2004 Sep; 27(5):319-30. PubMed ID: 15225982
[TBL] [Abstract][Full Text] [Related]
6. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of RT-PCR as a tool for diagnosis of secondary dengue virus infection.
Sa-ngasang A; Wibulwattanakij S; Chanama S; O-rapinpatipat A; A-nuegoonpipat A; Anantapreecha S; Sawanpanyalert P; Kurane I
Jpn J Infect Dis; 2003; 56(5-6):205-9. PubMed ID: 14695431
[TBL] [Abstract][Full Text] [Related]
8. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination.
Vázquez S; Valdés O; Pupo M; Delgado I; Alvarez M; Pelegrino JL; Guzmán MG
J Virol Methods; 2003 Jun; 110(2):179-84. PubMed ID: 12798246
[TBL] [Abstract][Full Text] [Related]
9. Partial inhibition of yellow fever virus replication in vitro with different phosphorothioate oligodeoxyribonucleotides.
Tolou H; Puggelli H; Tock F; Durand JP
Acta Virol; 1996 Apr; 40(2):73-9. PubMed ID: 8886115
[TBL] [Abstract][Full Text] [Related]
10. [Reflection on 2 current viral diseases: yellow fever and dengue].
Chastel C
Ann Biol Clin (Paris); 1997; 55(5):415-24. PubMed ID: 9347008
[TBL] [Abstract][Full Text] [Related]
11. Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.
Gaspar LP; Mendes YS; Yamamura AM; Almeida LF; Caride E; Gonçalves RB; Silva JL; Oliveira AC; Galler R; Freire MS
J Virol Methods; 2008 Jun; 150(1-2):57-62. PubMed ID: 18420285
[TBL] [Abstract][Full Text] [Related]
12. A modified PAP (peroxidase-anti-peroxidase) staining technique using sera from patients with dengue hemorrhagic fever (DHF): 4 step PAP staining technique.
Okuno Y; Fukunaga T; Srisupaluck S; Fukai K
Biken J; 1979 Dec; 22(4):131-5. PubMed ID: 399586
[TBL] [Abstract][Full Text] [Related]
13. Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay.
Wu SJ; Lee EM; Putvatana R; Shurtliff RN; Porter KR; Suharyono W; Watts DM; King CC; Murphy GS; Hayes CG; Romano JW
J Clin Microbiol; 2001 Aug; 39(8):2794-8. PubMed ID: 11473994
[TBL] [Abstract][Full Text] [Related]
14. Arbovirus studies in Luanda, Angola. 1. Virological and serological studies during a yellow fever epidemic.
Pinto MR; Filipe AR
Bull World Health Organ; 1973; 49(1):31-5. PubMed ID: 4545154
[TBL] [Abstract][Full Text] [Related]
15. Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate.
Liu CC; Wu SC
Biotechnol Bioeng; 2004 Mar; 85(5):482-8. PubMed ID: 14760688
[TBL] [Abstract][Full Text] [Related]
16. [Secondary serologic responses to dengue epidemic in 1998 in Salta, Argentina, where other flavivirus co-circulate].
Aviles G; Rangeon G; Paz MV; Baroni P; Sabattini MS; Enría D
Medicina (B Aires); 2001; 61(2):129-36. PubMed ID: 11374133
[TBL] [Abstract][Full Text] [Related]
17. Research on dengue in tissue culture. IV. Serologic responses of human beings to combined inoculations of attenuated, tissue-cultured type I dengue virus and yellow fever vaccine.
Fujita N; Oda K; Yasui Y; Hotta S
Kobe J Med Sci; 1969 Dec; 15(4):163-80. PubMed ID: 4317037
[No Abstract] [Full Text] [Related]
18. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
[TBL] [Abstract][Full Text] [Related]
19. Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus.
Yoshida CF; Rouzerè CD; Nogueira RM; Lampe E; Travassos-da-Rosa MA; Vanderborght BO; Schatzmayr HG
Braz J Med Biol Res; 1992; 25(11):1131-5. PubMed ID: 1285268
[TBL] [Abstract][Full Text] [Related]
20. A retrospective serological study of Japanese who contracted dengue fever in Thailand.
Fukunaga T; Okuno Y; Tadano M; Fukai K
Biken J; 1983 Jun; 26(2):67-74. PubMed ID: 6661173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
